EcoR1 Capital, LLC
All holdings · as of Dec 31, 2025
| Company | Value ↓ | % of portfolio |
|---|---|---|
| ZYMEWORKS INC. | $604.81M | 27.6% |
| AnaptysBio, Inc. | $382.03M | 17.4% |
| Jazz Pharmaceuticals PLC | $290.10M | 13.2% |
| Crinetics Pharmaceuticals, Inc. | $199.61M | 9.1% |
| CENTESSA PHARMACEUTICALS PLC | $77.91M | 3.6% |
| CRISPR THERAPEUTICS AG | $72.85M | 3.3% |
| MBX Biosciences, Inc.MBX | $66.98M | 3.1% |
| Immunome Inc. | $61.34M | 2.8% |
| Oric Pharmaceuticals, Inc. | $55.04M | 2.5% |
| GALAPAGOS NV | $54.51M | 2.5% |
| Xencor Inc | $49.77M | 2.3% |
| BridgeBio Oncology Therapeutics, Inc.BBOT | $35.35M | 1.6% |
| Eton Pharmaceuticals, Inc. | $34.34M | 1.6% |
| CG Oncology, Inc. | $32.05M | 1.5% |
| Zenas BioPharma, Inc.ZBIO | $28.67M | 1.3% |
| Neurogene Inc.NGNE | $26.19M | 1.2% |
| Structure Therapeutics Inc.GPCR | $23.26M | 1.1% |
| VAXCYTE, INC. | $20.76M | 0.9% |
| Aquestive Therapeutics, Inc.AQST | $16.96M | 0.8% |
| Voyager Therapeutics, Inc. | $15.73M | 0.7% |
| Atara Biotherapeutics, Inc.ATRA | $10.37M | 0.5% |
| MANNKIND CORP | $9.41M | 0.4% |
| NUVATION BIO INC | $8.63M | 0.4% |
| Evolus, Inc. | $4.49M | 0.2% |
| iBio, Inc.IBIO | $4.30M | 0.2% |
| Mereo BioPharma Group plcMREO | $3.27M | 0.1% |
| Camp4 Therapeutics Corp | $1.99M | 0.1% |
| SURROZEN INC | $100.4K | 0.0% |